Impulse Oscillometry -- also called the Forced Oscillation Technique (FOT) -- is a pulmonary function test unlike any other in your asthma workup. While spirometry asks you to blow out as hard and fast as possible, IOS asks almost nothing of you: simply breathe in and out normally through a mouthpiece. In 30-90 seconds, the device delivers a complete picture of airway resistance and lung stiffness across multiple airway generations -- from your trachea down to the smallest bronchioles that spirometry cannot reliably reach.
For patients whose asthma continues to cause symptoms despite apparently normal spirometry results -- a surprisingly common scenario -- IOS frequently reveals the underlying problem: peripheral small airway disease that the FEV1 and FVC ratios are simply not sensitive enough to detect. For children too young to reliably perform a forced expiratory maneuver, IOS provides objective lung function data where spirometry cannot. And for patients being evaluated for biologic therapy, IOS adds a phenotyping dimension that helps predict treatment response.
This guide explains exactly what IOS measures, how to interpret every parameter on your report, and why Dr. Frank Hull's team in Plantation, FL uses oscillometry as a complement to the standard pulmonary function battery.
What Is Impulse Oscillometry?
IOS (Impulse Oscillometry System) is a clinical implementation of the Forced Oscillation Technique, a method for measuring respiratory mechanics refined significantly over the past two decades. The core principle: a loudspeaker embedded in the mouthpiece device generates brief, nearly imperceptible pressure pulses -- "impulses" -- across a broad range of oscillation frequencies simultaneously (typically 5 Hz to 35 Hz). These pulses are superimposed on your normal tidal breathing. Pressure and flow sensors at the mouthpiece measure how your respiratory system responds to each frequency. Signal processing then separates out the system's resistance and reactance at each frequency.
The key insight is that different oscillation frequencies penetrate different airway depths. Low frequencies (5 Hz) have long wavelengths and travel deep into the peripheral small airways. High frequencies (20 Hz) have short wavelengths and are largely dissipated in the central large airways before reaching the periphery. By comparing the response at 5 Hz versus 20 Hz, IOS can estimate how much of total airway resistance originates from the peripheral versus central compartment -- something spirometry cannot do directly.
Why "Effort-Independent" Matters
Spirometry depends entirely on patient effort: you must inhale maximally, seal your lips tightly around the mouthpiece, and then blast air out as hard as possible for at least six seconds while a technician coaches you. Poor effort produces falsely low FEV1 and FVC values that look like disease when the airways are actually normal. IOS eliminates this confounder. Because measurements are made during quiet tidal breathing, patient effort does not influence the result. This makes IOS especially reliable for young children, elderly patients, those with severe dyspnea, and anyone who cannot perform a reproducible spirometry maneuver.
IOS Parameters: What Each Number Means
Every IOS report includes six primary parameters. Here is what each one measures and what an abnormal value means for asthma:
R5 -- Total Airway Resistance
Resistance measured at 5 Hz. Low-frequency oscillations penetrate both central and peripheral airways, so R5 reflects total respiratory resistance -- the sum of large and small airway contributions. It is the IOS parameter most analogous to the overall "obstruction" concept in spirometry, and typically the first to become abnormal in mild asthma.
Normal: less than 150% of predicted (age, sex, height-adjusted)
R20 -- Central Airway Resistance
Resistance measured at 20 Hz. High-frequency oscillations lose energy quickly and do not reach small airways, so R20 reflects primarily central large airway resistance. It tends to rise when there is large airway narrowing (e.g., upper airway obstruction, tracheal stenosis, central bronchospasm). In pure peripheral asthma, R20 may be entirely normal.
Normal: less than 150% of predicted
R5 minus R20 -- Peripheral Resistance
The difference between R5 and R20 is the best IOS estimate of peripheral small airway resistance. When R5 is elevated but R20 is normal, most of the resistance is coming from the small airways -- exactly what is seen in eosinophilic asthma with distal airway inflammation, in poorly controlled allergic asthma, and in fixed air trapping. A high R5-R20 is a strong argument for reviewing inhaler technique or switching to a small-particle inhaled corticosteroid.
Normal: less than 0.07 kPa/L/s in most adults
X5 -- Peripheral Reactance
Reactance at 5 Hz reflects the elastic and inertial properties of the lung rather than frictional resistance. Think of it as measuring how "springy" the peripheral airways are. Healthy peripheral lung tissue is relatively compliant -- X5 is a small negative number. When small airways are inflamed, obstructed, or air-trapped, the lung becomes stiffer: X5 becomes more negative. A markedly negative X5 is often the most sensitive single IOS marker for symptomatic asthma with preserved spirometry.
Normal: greater than -0.10 kPa/L/s (values more negative indicate small airway disease)
AX -- Reactance Area
AX is the area enclosed by the reactance curve between 5 Hz and the resonant frequency. It integrates frequency-dependent reactance into a single number that captures both the depth and breadth of peripheral airway dysfunction. AX is widely considered the most sensitive IOS parameter for detecting early or mild small airway disease. Elevated AX correlates strongly with asthma control questionnaire scores and sputum eosinophil counts in research studies.
Normal: less than 1.0 kPa/L (varies by reference equation)
Fres -- Resonant Frequency
The resonant frequency is the oscillation frequency at which reactance equals zero -- where inertance and compliance are balanced. In healthy lungs, Fres is low (typically 8-12 Hz). When peripheral airways are obstructed and lung compliance decreases, Fres rises, sometimes above 20-25 Hz in moderate-to-severe asthma. Elevated Fres indicates increased peripheral stiffness and is a useful severity marker that complements R5-R20 and X5.
Normal: less than 20 Hz (age-dependent)
IOS vs. Spirometry: How They Compare
IOS and spirometry answer different questions about the same respiratory system. They are complementary tools, not substitutes:
| Feature | Spirometry | Impulse Oscillometry (IOS) |
|---|---|---|
| Patient effort required | High -- maximal forced exhalation for 6+ seconds | None -- quiet tidal breathing only |
| Minimum reliable age | 5-6 years (some programs down to 4) | 2-3 years |
| Primary obstruction marker | FEV1/FVC ratio below LLN | Elevated R5, increased R5-R20, negative X5 |
| Small airway assessment | Indirect via FEF25-75% (high variability) | Direct via R5-R20, X5, AX |
| Central vs. peripheral separation | Not directly possible | Yes -- R20 (central) vs. R5-R20 (peripheral) |
| Sensitivity in mild asthma | May be normal with active symptoms | AX and X5 often abnormal before FEV1/FVC ratio drops |
| Measurement time | 15-30 min baseline; 45 min with bronchodilator | 10-15 min baseline; 30-40 min with bronchodilator |
| ATS/ERS standardized | Yes (2019 update) | Yes (ERS Technical Standard; updated guidance 2020) |
The practical clinical workflow at Advanced Asthma Clinic typically combines both tests: spirometry provides the reference standard FEV1/FVC measurement and confirms reversibility, while IOS adds the peripheral airway dimension and serves as the primary test when spirometry is not technically feasible.
Small Airway Disease in Asthma: Why It Matters
The small airways -- defined as those with an internal diameter less than 2 mm -- comprise roughly 98% of the total airway cross-sectional area of the lung. Historically called the "quiet zone" because early disease there produces few symptoms and minimal spirometry changes, the small airways are now understood to be a critical site of asthmatic inflammation, particularly in T2-high phenotypes driven by type 2 innate lymphoid cells (ILC2s), eosinophils, and IL-4/IL-5/IL-13 cytokine cascades.
Research using computed tomography (CT) air trapping maps, alveolar nitric oxide (CalvNO), and IOS has consistently shown that:
- Approximately 50% of patients with mild-to-moderate asthma have significant peripheral airway dysfunction detectable by IOS or CT despite a normal FEV1/FVC on spirometry.
- Uncontrolled small airway disease correlates with nocturnal symptoms, exercise-induced bronchoconstriction, and a higher rate of acute exacerbations.
- Small airway IOS parameters -- particularly AX and X5 -- correlate with blood and sputum eosinophil counts, making them a non-invasive surrogate for T2 inflammation monitoring.
- Switching from a standard-particle inhaled corticosteroid (ICS) to a small-particle ICS formulation (e.g., ciclesonide, extrafine beclomethasone/formoterol) improves IOS parameters before any change is detectable on spirometry in some patients.
For patients in South Florida's allergen-dense environment -- year-round mold, dust mites, and seasonal pollen from subtropical vegetation -- peripheral airway inflammation frequently drives persistent symptoms even when office spirometry looks reassuringly normal.
How the IOS Test Is Performed
The procedure is straightforward and well-tolerated by patients of all ages, including young children:
- Preparation: Height and weight are recorded (required for predicted value calculations). You will be asked to withhold short-acting bronchodilators (albuterol) for 4-6 hours before the test if assessing baseline function. Inhaled corticosteroids are not withheld.
- Positioning: You sit upright with your head in a neutral position. Cheeks are supported firmly with both hands to reduce upper airway wall compliance -- an important technical requirement, since unsupported cheeks can absorb oscillation energy and falsely elevate measured resistance.
- Mouthpiece breathing: You place your lips around the mouthpiece and breathe normally. A nose clip is applied. The device begins delivering oscillatory pressure pulses; you will feel nothing or at most a very slight vibration.
- Measurement: Each measurement lasts 30-90 seconds. Artifacts caused by swallowing, coughing, or irregular breathing are automatically flagged. Three to five acceptable measurements are averaged. The technician reviews coherence data to confirm measurement reliability.
- Bronchodilator step (optional): If reversibility assessment is ordered, albuterol 400 mcg is administered via metered-dose inhaler and spacer. Measurements are repeated 15 minutes later. A significant bronchodilator response is defined as improvement in R5 of 40% or greater, or improvement in AX of 40% or greater -- thresholds established by ERS guidance.
No radiation, no blood draw, no contrast. The test is safe for virtually all patients including pregnant women, those with pacemakers, and patients with very severe airflow limitation.
Interpreting Your IOS Results: Patterns in Asthma
IOS findings in asthma typically fall into three recognizable patterns, each with different clinical implications:
| Pattern | R5 | R20 | R5-R20 | X5 | Fres | Clinical Interpretation |
|---|---|---|---|---|---|---|
| Normal | Normal | Normal | Low | Normal (-0.05 to -0.10) | Low (<15 Hz) | No objective airway dysfunction at time of testing; asthma may be well controlled or test timed between exacerbations |
| Peripheral small airway disease | Elevated | Normal | High | Markedly negative | Elevated | Classic asthma IOS pattern; most of resistance is in small airways; may present with normal spirometry |
| Mixed central + peripheral | Elevated | Elevated | High | Markedly negative | Elevated | Widespread airway obstruction; seen in severe or poorly controlled asthma, COPD-asthma overlap |
| Central airway-predominant | Mildly elevated | Elevated | Low or normal | Near normal | Normal or mildly elevated | Suggests large airway pathology (vocal cord dysfunction, tracheobronchomalacia); less typical of asthma alone |
Within a single patient, serial IOS measurements over time are valuable for tracking treatment response. Successful biologic therapy typically normalizes X5 and AX before producing detectable changes in FEV1, reflecting early resolution of peripheral inflammation.
When Is IOS Ordered?
Dr. Frank Hull considers IOS testing in the following clinical situations:
- Persistent symptoms with normal spirometry: Patients with daily wheeze, chest tightness, or nocturnal awakenings whose FEV1/FVC ratio is normal or borderline -- IOS frequently confirms peripheral airway dysfunction not captured by standard spirometry.
- Pediatric lung function assessment: Children under 5-6 years who cannot reliably perform spirometry maneuvers; IOS provides objective data to guide inhaler type and dose adjustments in very young asthmatic patients.
- Biologic therapy candidacy and monitoring: Pre-treatment IOS establishes peripheral airway baseline; post-treatment IOS at 3-6 months quantifies response and supports continuation of biologic medications such as dupilumab, mepolizumab, or tezepelumab.
- Inhaler technique and device selection: Patients not responding to standard large-particle ICS may have dominant small airway disease; IOS helps identify this phenotype and supports switching to small-particle or extrafine formulations.
- COPD-asthma overlap: When both asthma and COPD features are present, IOS characterizes the relative central versus peripheral contributions to obstruction and guides therapy beyond standard GINA/GOLD algorithms.
- Exercise-induced bronchoconstriction evaluation: IOS before and after a standardized exercise protocol or methacholine challenge can quantify bronchial hyperresponsiveness in patients who lack spirometry-detectable responses.
- Clinical trial screening: Several current trials in severe asthma and COPD use IOS as an inclusion criterion or primary endpoint; participation may include IOS testing for eligible patients at Lung Research Florida.
IOS and Biologic Therapy in Severe Asthma
One of the most compelling applications of IOS is monitoring the response to FDA-approved biologic therapies in severe asthma. Patients with severe eosinophilic asthma eligible for anti-IL-5 agents (mepolizumab, benralizumab, reslizumab), anti-IL-4/IL-13 dupilumab, or anti-TSLP tezepelumab typically carry a significant burden of small airway eosinophilic inflammation.
IOS parameters offer earlier and more sensitive readout of biologic response than spirometry for these patients:
- AX and X5 normalize significantly at 12-16 weeks of biologic therapy, a time point at which FEV1 may have improved by only a few percentage points.
- Failure of IOS to improve at 16 weeks -- particularly failure of R5-R20 and AX to decrease -- may indicate incomplete T2 suppression and prompts reassessment of biologic choice or adherence.
- Persistent IOS abnormalities despite good spirometry control may explain continued exercise limitation or nocturnal awakenings in patients who report inadequate quality of life improvement on biologics.
Blood eosinophil counts and fractional exhaled nitric oxide (FeNO) remain the primary biomarkers for biologic selection. IOS provides the functional complement: objective, effort-independent measurement of whether the peripheral airways are actually opening up in response to treatment.
IOS in South Florida: Why Local Climate Adds Urgency
Broward County's subtropical climate creates a year-round allergenic burden that is among the highest in the United States. Outdoor mold spore counts peak in summer and during the rainy season (June through October). Indoor humidity above 50% promotes dust mite proliferation in upholstered furniture, carpet, and bedding. Cockroach allergen is prevalent in older housing stock. Pollen seasons overlap rather than occurring in discrete windows.
The result is that many Plantation, Fort Lauderdale, Davie, and Weston patients with allergic asthma never achieve the seasonal symptom reduction they would in a less humid climate -- their peripheral airways remain chronically inflamed even during months when spirometry looks acceptable. IOS captures this persistent small airway burden, allowing Dr. Hull to adjust step therapy, evaluate inhaled corticosteroid device and particle size choices, and determine when biologics are warranted for what appears "moderate" by spirometry criteria but is functionally severe by IOS evidence.
Preparing for Your IOS Appointment
What to Do Before the Test
- Withhold short-acting bronchodilators: Hold albuterol (Ventolin, ProAir, Proventil) for 4-6 hours before testing if a baseline measurement is needed.
- Withhold long-acting bronchodilators (LABAs): Salmeterol, formoterol, and vilanterol should be withheld for 12 hours; tiotropium (ultra-long) for 24 hours. Discuss with the clinic when scheduling.
- Continue inhaled corticosteroids: Do not stop your ICS -- it does not affect IOS baseline measurements and stopping is unsafe.
- Avoid smoking or vaping: At least 4 hours before the test.
- Avoid heavy meals: A light meal is fine; a large meal in the hour before can slightly alter respiratory mechanics.
- Wear comfortable clothing: Nothing tight around the chest or abdomen.
- Reschedule if acutely ill: An active respiratory tract infection or significant exacerbation will produce falsely severe measurements; testing during stable state is preferred for baseline evaluation.
What to Expect During the Visit
The clinic staff will explain cheek support technique (hands pressed firmly against cheeks to reduce buccal wall vibration artifact). You will be asked to breathe as quietly and regularly as possible. Swallowing and deep sighs trigger artifact rejection; the technician will coach you to maintain steady breathing. Most patients find IOS considerably easier and more comfortable than spirometry, particularly those who have previously struggled with the forced exhalation maneuver. Always consult your physician about whether IOS is the right test for your clinical situation.
Frequently Asked Questions About Impulse Oscillometry
What is impulse oscillometry (IOS)?
IOS is a lung function test that measures airway resistance and reactance by superimposing small, nearly imperceptible pressure oscillations onto your normal breathing. You simply breathe through a mouthpiece without any forced effort. A loudspeaker generates pressure pulses at multiple frequencies simultaneously, and sensors measure how your respiratory system responds. The result is a detailed assessment of resistance and stiffness in both central large airways and peripheral small airways -- information spirometry cannot provide directly.
What does R5 mean on an oscillometry report?
R5 is total respiratory resistance measured at 5 Hz. Because low-frequency oscillations penetrate deeper into the lungs, R5 reflects resistance in both large and small airways combined. An elevated R5 (above 150% of predicted for your age, sex, and height) indicates increased total airway resistance -- often the first IOS parameter to become abnormal in early or mild asthma.
What is the difference between R5 and R20 in IOS?
R20 is resistance measured at 20 Hz. High-frequency oscillations do not penetrate as deeply into the lung, so R20 primarily reflects central large airway resistance. The difference R5 minus R20 represents the peripheral small airway contribution to total resistance. A difference greater than 0.07 kPa/L/s in adults indicates significant peripheral airway disease -- a hallmark of eosinophilic asthma and the target of biologic therapies.
What does X5 (reactance) mean in oscillometry?
X5 is respiratory reactance at 5 Hz, reflecting how stiff or compliant the peripheral lung is. In healthy lungs, X5 is a small negative number. In asthma with small airway disease or air trapping, X5 becomes markedly more negative, indicating increased peripheral stiffness. AX (reactance area) integrates reactance across a frequency range and is the single most sensitive IOS marker for early small airway disease.
Can IOS detect asthma when spirometry is normal?
Yes -- this is one of IOS's most important clinical advantages. Many patients with symptomatic asthma have a normal FEV1/FVC ratio on spirometry yet show elevated R5, increased R5-R20, and a negative X5 on IOS. Research confirms that IOS parameters correlate with asthma control scores and sputum eosinophil counts even when spirometry is within normal limits, making IOS particularly valuable for patients with persistent symptoms and reassuring spirometry.
Who is IOS most useful for?
IOS is especially valuable for children as young as 2-3 years (no forced effort required), elderly patients who cannot generate reliable spirometry maneuvers, patients with severe dyspnea who cannot sustain a 6-second maximal exhalation, patients with suspected small airway disease despite normal spirometry, and patients being monitored on biologic therapy for severe asthma. It is also used when inhaler particle size is being optimized.
How long does an IOS test take?
Each IOS measurement takes 30-90 seconds of quiet tidal breathing. With three to five acceptable maneuvers and setup time, the baseline test takes 10-15 minutes. When bronchodilator reversibility is included (albuterol 400 mcg via spacer, 15-minute wait, repeat measurements), the total visit is approximately 30-40 minutes. IOS is often combined with spirometry in a single session for a comprehensive pulmonary function assessment.
Does Advanced Asthma Clinic offer impulse oscillometry in Plantation, FL?
Yes. Dr. Frank Hull's team at Advanced Asthma Clinic (10059 NW 1st Court, Plantation, FL 33324) offers impulse oscillometry as part of a comprehensive asthma evaluation. IOS can be performed alone or combined with spirometry, FeNO, and allergy testing. Call 954-522-7226 to schedule. The clinic serves patients from Fort Lauderdale, Davie, Weston, Sunrise, Pembroke Pines, and throughout Broward County.